270 related articles for article (PubMed ID: 32172730)
1. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner.
Kim SJ; Chun KH
BMB Rep; 2020 Apr; 53(4):173-180. PubMed ID: 32172730
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 in angiogenesis and metastasis.
Funasaka T; Raz A; Nangia-Makker P
Glycobiology; 2014 Oct; 24(10):886-91. PubMed ID: 25138305
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3--a jack-of-all-trades in cancer.
Newlaczyl AU; Yu LG
Cancer Lett; 2011 Dec; 313(2):123-8. PubMed ID: 21974805
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 as a multifunctional protein.
Krześlak A; Lipińska A
Cell Mol Biol Lett; 2004; 9(2):305-28. PubMed ID: 15213811
[TBL] [Abstract][Full Text] [Related]
5. On the role of galectin-3 in cancer apoptosis.
Nakahara S; Oka N; Raz A
Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
[TBL] [Abstract][Full Text] [Related]
6. Nuclear transport of galectin-3 and its therapeutic implications.
Funasaka T; Raz A; Nangia-Makker P
Semin Cancer Biol; 2014 Aug; 27():30-8. PubMed ID: 24657939
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
[TBL] [Abstract][Full Text] [Related]
8. Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking.
Funasaka T; Balan V; Raz A; Wong RW
Biochem Biophys Res Commun; 2013 Apr; 434(1):155-61. PubMed ID: 23541576
[TBL] [Abstract][Full Text] [Related]
9. Galectin 3 as a guardian of the tumor microenvironment.
Ruvolo PP
Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
Lima T; Perpétuo L; Henrique R; Fardilha M; Leite-Moreira A; Bastos J; Vitorino R
Mol Biol Rep; 2023 Mar; 50(3):2763-2778. PubMed ID: 36583779
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 and cancer (Review).
Califice S; Castronovo V; Van Den Brûle F
Int J Oncol; 2004 Oct; 25(4):983-92. PubMed ID: 15375548
[TBL] [Abstract][Full Text] [Related]
12. Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression.
Wang L; Guo XL
Biomed Pharmacother; 2016 Mar; 78():165-171. PubMed ID: 26898438
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 and metastasis.
Takenaka Y; Fukumori T; Raz A
Glycoconj J; 2002; 19(7-9):543-9. PubMed ID: 14758078
[TBL] [Abstract][Full Text] [Related]
14. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3.
Califice S; Castronovo V; Bracke M; van den Brûle F
Oncogene; 2004 Sep; 23(45):7527-36. PubMed ID: 15326483
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).
Dong R; Zhang M; Hu Q; Zheng S; Soh A; Zheng Y; Yuan H
Int J Mol Med; 2018 Feb; 41(2):599-614. PubMed ID: 29207027
[TBL] [Abstract][Full Text] [Related]
16. The role of galectin-3 in cancer drug resistance.
Fukumori T; Kanayama HO; Raz A
Drug Resist Updat; 2007 Jun; 10(3):101-8. PubMed ID: 17544840
[TBL] [Abstract][Full Text] [Related]
17. [Cancer-associated carbohydrate-binding protein galectin-3 and its therapeutic ligands].
Bai H; Liu L; Li YH; You Y; Mei QB
Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):129-34. PubMed ID: 18664176
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells.
Qiao L; Liang N; Xie J; Luo H; Zhang J; Deng G; Li Y; Zhang J
Mol Med Rep; 2016 Jan; 13(1):160-6. PubMed ID: 26718452
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway.
Alge-Priglinger CS; André S; Schoeffl H; Kampik A; Strauss RW; Kernt M; Gabius HJ; Priglinger SG
Biochimie; 2011 Mar; 93(3):477-88. PubMed ID: 21094672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
